Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Children's Hospital Medical Center, Cincinnati
Age
5–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Ability to provide written informed consent (and if applicable, Assent) and comply with study assessments for the full duration of the study;
Enrolled without regard to gender, race, ethnicity;
Age \> 5 years to \< 18 years;
Diagnosis of Ulcerative Colitis (UC);
Remission or mild disease activity defined by a PUCAI \<34;
Subjects taking stable doses (defined as 30 days) of all UC medications including AZA/6-MP, methotrexate, mesalamine, or infliximab at entry will be included;
Willing to use birth control during study participation for females of child-bearing potential, as determined by investigator.
You may not be if
Current use, or use in the last 3 months, of probiotic preparations, not including yogurt;
Known history of HIV or other known immunocompromised disease;
Any central vascular line;
Concomitant administration of an antibiotic, and must be off antibiotics for at least one month prior to enrollment;
Cardiac valvular disease;
Any other condition requiring current hospitalization for treatment;
Current use of prednisone or budesonide;
Diagnosis of Crohn's disease or indeterminate colitis;
Pregnancy (positive pregnancy test) prior to enrollment in the study for females of child-bearing potential;
Females of child-bearing potential who are unwilling to use birth control during study participation;
Any other condition that the investigator believes would pose a significant hazard to the subject if the investigational therapy were initiated;
Participation in another simultaneous clinical trial involving a drug or biological other than participation in the Pediatric IBD Registry and/or the Pediatric IBD Network for Research and Improvement.
